Consun Pharma

Consun Pharma, a Pharmaceutical Preparation Manufacturing company headquartered in China, has reported its carbon emissions for various years.

In 2022, Consun Pharma's total reported emissions were approximately 72.06 million kg CO2e. This included about 53.21 million kg CO2e from Scope 1 emissions, which covers direct emissions from owned or controlled sources, and approximately 18.84 million kg CO2e from Scope 2 emissions, which accounts for indirect emissions from the generation of purchased energy.

For 2021, the company reported total emissions of around 71.15 million kg CO2e, with Scope 1 emissions at approximately 52.55 million kg CO2e and Scope 2 emissions at about 18.60 million kg CO2e.

In 2020, Consun Pharma's total emissions were approximately 31.86 million kg CO2e, comprising about 16.42 million kg CO2e from Scope 1 and roughly 15.44 million kg CO2e from Scope 2.

The company's 2019 emissions data shows total Scope 1 and 2 emissions of approximately 28.16 million kg CO2e, with Scope 1 at about 15.47 million kg CO2e and Scope 2 at roughly 12.69 million kg CO2e.

In 2017, Consun Pharma's total emissions were approximately 21.05 million kg CO2e, including around 12.61 million kg CO2e from Scope 1 and about 7.98 million kg CO2e from Scope 2.

Consun Pharma has not disclosed specific Scope 3 emissions data for any of the reported years. There are no publicly available carbon reduction targets or commitments, such as those verified by the Science Based Targets initiative (SBTi) or participation in The Climate Pledge. Emissions data and performance information are sourced directly from Consun Pharmaceutical Group Limited.